Katie Albert, MD

Cancer and Blood Disorders Center, Neuroblastoma Program, Bone Tumors and Soft Tissue Tumors, I-131-MIBG Therapy, Solid Tumors Oncology

On staff since May 2016

Academic Title: Assistant Professor

"My overarching career goal is to improve the outcomes and quality of life for pediatric and young adult cancer patients, with a focus on those with musculoskeletal tumors (sarcomas) and other high-risk solid tumors. "

Be the first to recommend Dr. Katie Albert
Book Chapters

Albert CM and Pollack SM (Trent JC, Rosenberg AE, Pollack R, Delaney TF, eds)
Immunotherapy for Sarcoma
Sarcomas: Evidence-Based Diagnosis and Management, 2020 : 365-386

Albert CM (Arcara K and Tschudy M, eds)
Oncology
The Harriet Lane Handbook, 19th edition, 2011 June

Other Publications

Vitanza NA, Johnson AJ, Wilson AL, Brown C, Yokoyama JK, KÃ¼nkele A, Chang CA, Rawlings-Rhea S, Huang W, Seidel K, Albert CM, Pinto N, Gust J, Finn LS, Ojemann JG, Wright J, Orentas RJ, Baldwin M, Gardner RA, Jensen MC, Park JR
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis.
34253928 Nature medicine, 2021 July 12

Parsons E, Albert C, Forouhar M, Kunz A, Sainato R
Recurrent Severe Staphylococcus epidermidis Urinary Tract Infections in a 7-Year-Old Boy.
34100657 Clinical pediatrics, 2021 July : 60(8)346-349

Wenger TL, Bly RA, Wu N, Albert CM, Park J, Shieh J, Chenbhanich J, Heike CL, Adam MP, Chang I, Sun A, Miller DE, Beck AE, Gupta D, Boos MD, Zackai EH, Everman D, Ganapathi S, Wilson M, Christodoulou J, Zarate YA, Curry C, Li D, Guimier A, Amiel J, Hakonarson H, Webster R, Bhoj EJ, Perkins JA, Dahl JP, Dobyns WB
Activating variants in PDGFRB result in a spectrum of disorders responsive to imatinib monotherapy.
32500973 American journal of medical genetics. Part A, 2020 July : 182(7)1576-1591

Hong DS, DuBois SG, Kummar S, Farago AF, Albert CM, Rohrberg KS, van Tilburg CM, Nagasubramanian R, Berlin JD, Federman N, Mascarenhas L, Geoerger B, Dowlati A, Pappo AS, Bielack S, Doz F, McDermott R, Patel JD, Schilder RJ, Tahara M, Pfister SM, Witt O, Ladanyi M, Rudzinski ER, Nanda S, Childs BH, Laetsch TW, Hyman DM, Drilon A
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.
32105622 The Lancet. Oncology, 2020 April : 21(4)531-540 PMCID:PMC7497841

Davis JL, Lockwood CM, Stohr B, Boecking C, Al-Ibraheemi A, DuBois SG, Vargas SO, Black JO, Cox MC, Luquette M, Turpin B, Szabo S, Laetsch TW, Albert CM, Parham DM, Hawkins DS, Rudzinski ER
Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal Tumors.
30585824 The American journal of surgical pathology, 2019 April : 43(4)435-445

Crumm CE, Crotty EE, Albert CM, Blair AB, Otjen JP, Feldman KW
Atraumatic Spinal Epidural Hematoma as Initial Presentation of Hemophilia A in an Infant.
30870339 Pediatric emergency care, 2019 March 12

Albert CM, Davis JL, Federman N, Casanova M, Laetsch TW
TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening.
30592640 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019 Feb. 20 : 37(6)513-524

Baheti AD, Chapman T, Rudzinski E, Albert CM, Stanescu AL
Diagnosis, histopathologic correlation and management of hepatoblastoma: What the radiologist needs to know.
30172849 Clinical imaging, 2018 Nov. : 52273-279

DuBois SG, Laetsch TW, Federman N, Turpin BK, Albert CM, Nagasubramanian R, Anderson ME, Davis JL, Qamoos HE, Reynolds ME, Cruickshank S, Cox MC, Hawkins DS, Mascarenhas L, Pappo AS
The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas.
30204247 Cancer, 2018 Nov. 1 : 124(21)4241-4247 PMCID:PMC6263791

Laetsch TW, DuBois SG, Mascarenhas L, Turpin B, Federman N, Albert CM, Nagasubramanian R, Davis JL, Rudzinski E, Feraco AM, Tuch BB, Ebata KT, Reynolds M, Smith S, Cruickshank S, Cox MC, Pappo AS, Hawkins DS
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.
29606586 The Lancet. Oncology, 2018 May : 19(5)705-714 PMCID:PMC5949072

Ronsley R, Rassekh SR, Shen Y, Lee AF, Jantzen C, Halparin J, Albert C, Hawkins DS, Amed S, Rothstein R, Mungall AJ, Dix D, Blair G, Nadel H, Jones SJM, Laskin J, Marra MA, J Deyell R
Application of genomics to identify therapeutic targets in recurrent pediatric papillary thyroid carcinoma.
29610391 Cold Spring Harbor molecular case studies, 2018 April : 4(2) PMCID:PMC5880264

Davis JL, Lockwood CM, Albert CM, Tsuchiya K, Hawkins DS, Rudzinski ER
Infantile NTRK-associated Mesenchymal Tumors.
28683589 Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society, 2018 Jan. : 21(1)68-78

Hayashi M, Baker A, Goldstein SD, Albert CM, Jackson KW, McCarty G, Kahlert UD, Loeb DM
Inhibition of porcupine prolongs metastasis free survival in a mouse xenograft model of Ewing sarcoma.
29108227 Oncotarget, 2017 Oct. 3 : 8(45)78265-78276 PMCID:PMC5667961

Hayashi M, Zhu P, McCarty G, Meyer CF, Pratilas CA, Levin A, Morris CD, Albert CM, Jackson KW, Tang CM, Loeb DM
Size-based detection of sarcoma circulating tumor cells and cell clusters.
29108279 Oncotarget, 2017 Oct. 3 : 8(45)78965-78977 PMCID:PMC5668012

Hayashi M, Chu D, Meyer CF, Llosa NJ, McCarty G, Morris CD, Levin AS, Wolinsky JP, Albert CM, Steppan DA, Park BH, Loeb DM
Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA.
27351911 Cancer, 2016 Oct. : 122(19)3015-23 PMCID:PMC5102400

Goldstein SD, Hayashi M, Albert CM, Jackson KW, Loeb DM
An orthotopic xenograft model with survival hindlimb amputation allows investigation of the effect of tumor microenvironment on sarcoma metastasis.
26278104 Clinical & experimental metastasis, 2015 Oct. : 32(7)703-15

Huang X, Park H, Greene J, Pao J, Mulvey E, Zhou SX, Albert CM, Moy F, Sachdev D, Yee D, Rader C, Hamby CV, Loeb DM, Cairo MS, Zhou X
IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas.
26173023 PloS one, 2015 : 10(7)e0133152 PMCID:PMC4501840

Dean JB, Hayashi SS, Albert CM, King AA, Karzon R, Hayashi RJ
Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens.
18376265 Journal of pediatric hematology/oncology, 2008 Feb. : 30(2)130-4

Albert CM and Pollack SM
Immunotherapy for Synovial Sarcoma
AIMS Medical Science, 2019 : 6(3)191-200
Show More Hide

Grant Title	Grantor	Amount	Award Date
Pediatric Cancer Data Commons	St. Baldrick’s Foundation		July 1, 2019 - June 30, 2022
Clinical Research Scholars Program	Seattle Children's Research Institute		Oct. 1, 2018 - Sept. 30, 2020